Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/4CF99673.svg?ark=w1%2F20260515%2F4CF99673)](https://nobleid.org/work/w1/20260515/4CF99673)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors